Legend Biotech Capital Expenditures (CapEx) Growth & History (LEGN)

Legend Biotech's capital expenditures (capex) was $28.6M for fiscal 2025.

View full Legend Biotech company overview

Legend Biotech annual capital expenditures (capex) history

Legend Biotech annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20252025-12-31$28.6M$14.5M+102.84%
20242024-12-31$14.1M−$6.0M−29.85%
20232023-12-31$20.1M−$827,000−3.95%
20222022-12-31$20.9M−$21.3M−50.41%
20212021-12-31$42.2M$15.9M+60.73%
20202020-12-31$26.3M−$519,000−1.94%
20192019-12-31$26.8M$5.8M+27.75%
20182018-12-31$21.0M

Legend Biotech capital expenditures (capex) trends

Over the last five fiscal years, Legend Biotech's capital expenditures (capex) increased from $26.3M to $28.6M, a change of $2.3M. The latest reported quarter, Q2 2026, shows $7.5M.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Legend Biotech source filings ↗

Community posts

It’s quiet here.

No posts about LEGN yet. Start the conversation.

Write the first post